You're watching...
Fuse Science CEO Brian Tuffin and entrepreneur Daymond John on the success of the company’s energy supplements.
Also in this playlist...
Auto-advance: ON
Auto-advance
This transcript is automatically generated
As that's a perfect question and this is why we sort of -- it is the evolution of energy.
You know in this technology actually we have half the caffeine that are in those products we have notorious.
Or any of the things that have been associated with any other negative side effects of that nature.
And it delivers it in a way that has no crash -- no.
After side effects so.
We're very very happy to have these products allow people to perform at their natural best.
And we're excited about that -- differentiates.
The technology.
Actually logic to limited.
Cut the dose in half a look at the effect -- -- actually older.
Products out that's -- -- -- -- -- -- I gotta believe no longer isn't anything let's -- can make a profit but I would imagine the implications for this.
That just as it is a great.
But medically I mean to pharmaceutical companies is if you can have a faster delivery -- method for medication are you looking at this are you looking at merging with a pharmacy.
Well -- I hit out at the I think this is the first stage of it and I think this is the proof of concept and -- people understand approval -- and I think that.
-- Bryant has big big you know goals for this hasn't yet this could be absolutely game change -- with what it currently is doing.
But -- -- told you know to that -- actually talking to -- well you can't name but you're actually in talks to this kind of discussion.
Well.
Late last fall in October we announced.
Proof of concept that we've been able to within our matrix actually deliver insulin through the -- Dervis.
We've been able to deliver -- -- Taxol extra dial.
A host of different actives and we believe in our operation that we're only limited by our imagination.
And so we announced in December.
A strategic licensing and -- and a process where we are in talks -- Some of the leading OTC and -- pharmaceutical players and that's part of our strategy.
But on this -- -- says so I -- favored grinder and a discussion and I apologize you get the last what what's most important thing you want people enough.
Well what people know that you know I don't I don't work with anything that is not.
A great product the easiest thing to sell the truth.
I think that I can make this.
A lifestyle product I think everybody will -- -- very shortly and Eagles all the way back for the product and I think -- he's gonna have a lot of -- extensions licensing branding.
Is -- love the idea of it I think you both for being here I don't know if I can never give up my fifteen cups of coffee a day but this is intriguing and I -- both the best.
Thank you very much you -- they care.
